Researcher with a Ph.D. in Virology and Gene Therapy with an extensive background in virology, molecular biology, and cell biology. Research experience and expertise includes bioinformatics variant analysis of viral genomes (measles virus and SARS-CoV2), engineering recombinant measles viruses, characterization of rescued measles viruses and relevant assay development. Additional laboratory experience in characterizing oncolytic adenovirus behavior in hypoxic conditions. I am looking for translational platforms that use measles virus vectors for reprogramming, gene editing or oncolytic virotherpay to expand my knowledge of and experience in measles virus biology.
Analyzed RNAseq data from brain infected with measles virus MeV (viral reads, frequencies and variant analysis). Cloned and rescued recombinant MeV and performed various assays to determine mutant virus fitness on different cell types. Performed Immunohistochemistry and in situ hybridization on human brain tissues and cell lines. Helped establish assay for SARS CoV2 RNA detection in wastewater to monitor and predict local COVID-19 outbreaks.
Identified a novel mechanism of adenovirus induced upregulation of a cellular gene called Hypoxia inducible factor 1 (HIF-1). Cloned and purified oncolytic adenovirus. Performed tissue culture in hypoxic conditions (both induced and in hypoxia chamber) to study virus behavior. Analyzed effects of hypoxia on virus via protein and RNA levels analyses.
Performed DNA extraction from Hepatitis C virus patient blood samples. Developed an assay to detect single cell polymorphism in Il28b in patients with HCV.
Performed diagnostic tests on samples from Tuberculosis patients.